Related Experiment Video
Updated: Feb 16, 2026

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
The HIV co-receptor CCR5 regulates osteoclast function
Ji-Won Lee1, Akiyoshi Hoshino2, Kazuki Inoue3
1Division of Bio-Imaging, Proteo-Science Center (PROS), Ehime University, Ehime, 791-0295, Japan. jwlee@m.ehime-u.ac.jp.
Abstract:
C-C chemokine receptor 5 (CCR5) is a co-receptor of HIV. Epidemiological findings suggest that the functional loss of CCR5 is correlated with a lower incidence of bone-destructive diseases as well as of HIV transmission. However, it is not clear whether CCR5 is involved in regulation of the function of bone cells, in addition to that of immune cells. Here we show that blockade of CCR5 using specific antibodies impairs human osteoclast function in vitro. Ccr5-deficient (Ccr5 -/- ) mice presented with dysfunctional osteoclasts and were resistant to osteoporosis induced by receptor activator of nuclear factor kappa-B ligand (RANKL), which triggers osteoporosis independently of inflammatory and immunomodulatory pathways. Furthermore, Ccr5 deficiency impairs the cellular locomotion and bone-resorption activity of osteoclasts, which is associated with the disarrangement of podosomes and adhesion complex molecules including Pyk2. Overall, the data provides evidence that CCR5 has an essential role in bone-destructive conditions through the functional regulation of osteoclasts.
Insights
C-C chemokine receptor 5 (CCR5) regulates osteoclast function, impacting bone destruction. Blocking CCR5 impairs osteoclast activity, offering potential therapeutic targets for bone diseases.
Area of Science:
- Immunology
- Bone Biology
- Cell Biology
Background:
- C-C chemokine receptor 5 (CCR5) is a known co-receptor for HIV entry.
- CCR5's absence correlates with reduced HIV transmission and bone-destructive diseases.
- Its role in bone cell regulation remains largely uncharacterized.
Purpose of the Study:
- To investigate the role of CCR5 in osteoclast function and bone metabolism.
- To determine if CCR5 blockade affects osteoclast activity and bone resorption.
Main Methods:
- In vitro studies using human osteoclasts and specific CCR5-blocking antibodies.
- In vivo studies utilizing Ccr5-deficient (Ccr5-/-) mice.
- Assessment of osteoclast function, cellular locomotion, and bone resorption activity.
Main Results:
- CCR5 blockade in vitro significantly impaired human osteoclast function.
- Ccr5-/- mice exhibited dysfunctional osteoclasts and resistance to RANKL-induced osteoporosis.
- CCR5 deficiency led to impaired osteoclast locomotion and bone resorption, linked to podosome and Pyk2 disarrangement.
Conclusions:
- CCR5 plays a critical role in regulating osteoclast function.
- CCR5 is essential for bone resorption and is implicated in bone-destructive conditions.
- Targeting CCR5 presents a potential therapeutic strategy for osteoporosis and other bone diseases.
Related Concept Videos
Osteoclasts in Bone Remodeling
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
GPCRs Regulate Adenylyl Cylase Activity
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...

